CCL5 and posterior cortical atrophy: Along this line, we recently found that the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, gefitinib decreased the capability of supernatants from PCa cells to increase CCL5 secretion by MSCs [74].